Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Aspergillosis (Phase 3)

Bacteremia (Phase 3)

Bacterial Infections (Phase 3)

Candidemia (Phase 3)

Candidiasis (Phase 3)

Candidiasis, Invasive (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Cellulitis (Phase 3)

Communicable Diseases (Phase 3)

Dermatitis (Phase 3)

Eczema (Phase 3)

Fever (Phase 3)

Glioblastoma (Phase 2)

Gram-Positive Bacterial Infections (Phase 3)

Hand Dermatoses (Phase 3)

Healthcare-Associated Pneumonia (Phase 3)

Infections (Phase 3)

Invasive Fungal Infections (Phase 3)

Kidney Failure, Chronic (Phase 1)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Lupus Erythematosus, Cutaneous (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Mycoses (Phase 3)

Neoplasms (Phase 1)

Neutropenia (Phase 3)

Pneumonia (Phase 3)

Pneumonia, Ventilator-Associated (Phase 1)

Pseudomonas Infections (Phase 3)

Psoriasis (Phase 2)

Renal Insufficiency (Phase 1)

Skin Diseases (Phase 3)

Skin Diseases, Bacterial (Phase 3)

Skin Diseases, Infectious (Phase 3)

Staphylococcal Skin Infections (Phase 3)

Streptococcal Infections (Phase 1)